| GTO ID | GTC1590 |
| Trial ID | NCT02686372 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | HBV gene |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HBV TCR-T cells |
| HLA | HLA-A*02 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I Study of T Cell Receptor-Redirected T Cell Infusion For Prevention of Hepatocellular Carcinoma Recurrence in Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma Post Liver Transplantation |
| Year | 2016 |
| Country | China |
| Company sponsor | Lion TCR Pte. Ltd. |
| Other ID(s) | LTCR-HCC-1-1 |
| Cohort 1 | |||||||||
|
|||||||||